Objectives: to analyse in-hospital outcomes and prognostic implications of reduced sodium serum level (S-Na) in patients with acute coronary syndrome including ST elevation myocardial infarction (STEMI) and non ST elevation myocardial infarction (non-STEMI).
Introduction
Hyponatremia, defined as a serum sodium concentration of <135 mmol/L, is the most common electrolyte abnormality in hospitalized patients (1, 2) . Hyponatremia often signifies poor prognosis(3). It is a predictor of mortality in patients with heart failure (4,5) and in patients with ST-elevation myocardial infarction (STEMI) (6,7). There is complex neuro-hormonal activation in acute myocardial infarction related to activation of the renin-angiotensin system, release of atrial natriuretic peptide and catecholamines (8, 9) . These mechanisms are similar to those in heart failure and lead to peripheral vasoconstriction and myocardial hypertrophy, with potential to worsen survival in acute myocardial infarction. The fall in sodium concentrations in patients with acute myocardial infarction is related to the previous mechanisms (6,10). While the prognostic value of hyponatremia in chronic heart failure is well established, data on the prognostic importance of hyponatremia in the setting of acute myocardial infarction are lacking, also few studies have focused on outcome in the elderly age group. This study is being undertaken to determine the prognostic significance of hyponatremia in the setting of acute coronary syndrome and to determine its usefulness in predicting short term (30-days) adverse outcomes.
Subjects and Methods
A cross sectional study was conducted on one hundred elderly males and females. Participants were recruited from cardiology intensive care unit in Ain Shams University hospitals. Elderly with the diagnosis of acute STEMI and non-STEMI were included. During the hospital stay, all participants underwent comprehensive geriatric assessment, medication review, cognitive assessment by which delirious patients were excluded, also subjects with history of heart failure, renal failure and hepatic patients were excluded; patients with history of diuretic use were also excluded.
Patients had clinical examination done and investigations in the form of serial ECG and cardiac enzymes, Echocardiography, laboratorial investigations for assessment of other Co-morbidities as complete blood picture, lipid profile, renal functions and blood glucose levels, also all participants had serum sodium levels obtained on admission and at 48 hours.
Laboratorial investigations were collected from medical reports. Diagnosis of myocardial infarction was done according to the criteria of the Joint European Society of Cardiology and American College of Cardiology in which diagnosis requires a finding of the typical rise and fall of biochemical markers of myocardial necrosis in addition to at least 1 of the following (11): o Ischemic symptoms o Development of pathologic Q waves o Ischemic ST-segment changes on electrocardiogram (ECG) or in the setting of a coronary intervention
Renal insufficiency and anemia were defined as admission values for creatinine >1.4 mg/dl and <12 mg/dl for hemoglobin, respectively. The follow-up for myocardial infarction recurrence and mortality was done through post discharge phone calls and the follow up duration was 30 days.
Statistical methods:
The collected data were coded, tabulated, revised and statistically analyzed using SPSS program (version 20). Descriptive statistics were done using mean and standard deviation for numerical parametric data and by number and percentage for categorical data. Statistical analysis was done for quantitative variables by using independent t-test in case of two independent groups, and paired t-test in related samples with parametric data. Chi-square test was used for non parametric data and Logistic regression analysis for predictors of mortality. The level of significance was taken at P value < 0.05.
Results
Baseline sociodemographic and clinical Characteristics of Patients are shown in Table 1 -next page.
There is no statistically significant difference between Na level on admission and after 48 hours as shown in Table 2 -page 15.
Comparison between hyponatremic and normonatremic groups shows no statistically significant difference between the two groups as regards sociodemographic variables, Co morbidities (diabetes, hypertension, anemia, renal impairment or hypercholesterolemia or old stroke), presence of hypotension on admission, pulmonary edema on admission or type of myocardial infarction, while ejection fraction was significantly lower in the hyponatremic group (Table 3) .
Relation between baseline patients' characteristics and outcome is demonstrated in Table 4 , which shows that both hypotension on admission and hyponatremia are significantly associated with poor outcome (mortality, MI recurrence).
Significant relation between poor outcome, EF, cardiac enzymes and sodium level on admission is shown in Table 5 .
Significant clinical variables were entered into a multivariate regression model which showed that hypotension on admission and hyponatremia are each significantly associated with 30-days adverse outcomes (Table 6 ).
Discussion
The results of this cross sectional study demonstrated that hyponatremia is common in elderly patients presenting with acute coronary syndrome and that hypotension on admission and hyponatremia were each significantly associated with recurrent myocardial infarction or death within 30 days of hospitalization.
Reviewing literature, data from several studies support the present study results. Flear et al (12) reported that hyponatremia, hypochloremia, and uremia were common in patients with confirmed myocardial infarction, with higher in-hospital mortality in hyponatremic patients, also Hochman et al (13) reported that hyponatremia in these patients was correlated with higher mortality and reflected severity of underlying disease; another study by Goldberg et al (7) showed an association between hyponatremia and increased 30-days mortality in patients with STEMI.
Bogdan et al (14) reported a high prevalence of hyponatremia within the first 72 hours of transmural myocardial infarction and Klopotowski et al (15) reported that patients with acute myocardial infarction developed hyponatremia on admission or within the first 48 after admission.
In this study age, sex, smoking, diabetes, hypertension, anemia, renal impairment, hypercholesterolemia, and pulmonary edema on admission were not associated with death/myocardial infarction. On the other hand hypotension on admission, hyponatremia on admission, ejection fraction and CPK & CPK -MB levels were significantly associated with recurrent myocardial infarction and death within 30 days and that is agreed with by Qing Tang & Qi Hua (16) who reported that gender, diabetes, hypertension, renal insufficiency, and hyperglycemia were not significantly associated with inhospital mortality and also with Singla et al (10) who reported that hypotension on admission and hyponatremia on admission were each significantly associated with the primary end point (combined incidence of death or new myocardial infarction within 30 days of index hospitalization), while diabetes mellitus and hypertension were not associated with death/myocardial infarction.
Qing Tang & Qi Hua (16) observed that patients with hyponatremia had lower ejection fractions than those without and stated that large infarct size resulted in ventricular dysfunction and might be responsible for these adverse outcomes therefore hyponatremia may be a simple parameter which reflects the presence of heart failure and that was in agreement with our study results as well.
Finally, it can be concluded that hyponatremia is considered a strong predictor for poor short term outcome in elderly with acute coronary syndrome.
Study limitations :
Our study has some limitations. Importantly, this was a small single site observational study also patients with hyperglycemia were not excluded which may be a contributing factor for hyponatremia.
Conclusion
Hyponatremia is associated with 30days adverse outcome in patients presenting with acute coronary syndrome. 
